MCRA Expands Evidence Generation Service Line to Ensure Early Stakeholder Engagement for Optimal Product Adoption

September 20, 2021

WASHINGTON , MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Cybersecurity is pleased to announce Mitali Stevens , PharmD., BCPS., has joined MCRA as Director, Reimbursement Strategy & Evidence Development.

Read the source article at PR Newswire
2021-09-15 21:18:00

Share This Story!